| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/19/2004 | CA2494014A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2493575A1 Tyrosine kinase inhibitors |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1389617A1 Heterocyclic compound and antitumor agent containing the same as active ingredient |
| 02/18/2004 | EP1389460A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound |
| 02/18/2004 | EP1389205A1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 02/18/2004 | EP1389204A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 02/18/2004 | EP1389203A2 Analogs of thalidomide as potential angiogenesis inhibitors |
| 02/18/2004 | EP1389194A2 Inhibitors of bace |
| 02/18/2004 | EP1389190A1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
| 02/18/2004 | EP1389104A2 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists |
| 02/18/2004 | EP1389100A2 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors |
| 02/18/2004 | EP1216248B1 Triazolopyrimidine derivatives |
| 02/18/2004 | EP1183252B1 pharmaceutically active compounds |
| 02/18/2004 | EP1133477B1 Substituted benzimidazoles and their use as parp inhibitors |
| 02/18/2004 | EP0974589B1 Benzimidazole derivatives and pharmaceutically acceptable salts thereof |
| 02/18/2004 | CN1476448A Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 02/18/2004 | CN1476446A Benzodiazepine derivative |
| 02/18/2004 | CN1476436A Novel compounds for use as HIV protease inhibitors |
| 02/18/2004 | CN1476432A Indole and dihydroindole derivatives |
| 02/18/2004 | CN1476429A EP4 receptor selective agonists in treatment of osteoporosis |
| 02/18/2004 | CN1138773C 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2 |
| 02/18/2004 | CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 02/17/2004 | US6693200 2-(substituted-phenyl)amino-imidazoline derivatives |
| 02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
| 02/17/2004 | US6693101 Alkanoic acid derivative; integrin receptor antagonist |
| 02/17/2004 | US6693097 Antiinflammatory agents; antidiabetic agents; skin disorders; rheumatic diseases |
| 02/17/2004 | CA2302965C Processes and intermediates for preparing anti-cancer compounds |
| 02/17/2004 | CA2290918C Heteroaromatic bicyclic derivatives useful as anticancer agents |
| 02/17/2004 | CA2280279C Indole, indazole and benzimidazole derivatives as antithrombotic agents |
| 02/12/2004 | WO2004013140A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 02/12/2004 | WO2004013129A1 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines |
| 02/12/2004 | WO2004013128A1 Novel substituted benzamides production and use thereof as medicaments |
| 02/12/2004 | WO2004013098A1 Novel gamma-lactams as beta-secretase inhibitors |
| 02/12/2004 | WO2004013091A2 4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases |
| 02/12/2004 | WO2004012776A1 Isotopically labelled indolinone derivatives and process for their preparation |
| 02/12/2004 | WO2004012648A2 Substituted diaryl heterocycles, method for the production and use thereof as medicaments |
| 02/12/2004 | WO2003070236A3 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | US20040030080 Water-dispersible, cationic polymers, a method of making same and items using same |
| 02/12/2004 | US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/12/2004 | US20040029933 Substituted phenylacetic acids |
| 02/12/2004 | US20040029902 2,4-Pyrimidinediamine compounds and their uses |
| 02/12/2004 | US20040029901 Obesity therapy; administering orlistat |
| 02/12/2004 | US20040029888 Central nervous system disorders; psychological disorders |
| 02/12/2004 | US20040029876 Acylamino cyclopropane derivatives |
| 02/12/2004 | US20040029875 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 02/12/2004 | US20040029858 Antitumor agents; solid tumors of rectum, lungs |
| 02/12/2004 | US20040029857 Anticancer agents; central nervous system disorders; antiinflamamtory agents |
| 02/12/2004 | US20040029812 Skin disorders; aging resistance |
| 02/12/2004 | DE10233817A1 Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted Diarylheterocyclen, processes for their preparation and their use as medicaments |
| 02/12/2004 | DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments |
| 02/12/2004 | CA2493749A1 4-trifluoromethylpyrazolyl substituted pyridines and pyrimidines |
| 02/11/2004 | EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/11/2004 | EP1387850A2 Antiviral nucleosides |
| 02/11/2004 | EP1387826A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 02/11/2004 | EP1387679A1 Sulfonamides |
| 02/11/2004 | EP1299356B1 Novel compounds |
| 02/11/2004 | EP1274702B1 Process for the synthesis of a known tetrazol derivative |
| 02/11/2004 | EP1216239B1 Piperazine derivatives as 5-ht1b antagonists |
| 02/11/2004 | EP1157998B1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 02/11/2004 | EP1034169B1 Trisaryl-1,3,5-triazine ultraviolet light absorbers |
| 02/11/2004 | EP1020462B1 Heterocyclic compounds and antitumor agent containing the same as active ingredient |
| 02/11/2004 | EP1006110B1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 02/11/2004 | CN1474815A 4-amino-quinazolines |
| 02/11/2004 | CN1474814A Process for producing substituted aniline compound |
| 02/11/2004 | CN1474702A Oral pharmaceutical composition containing a block copolymer |
| 02/11/2004 | CN1473825A Process for preparing voriconazole |
| 02/11/2004 | CN1137886C Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 02/11/2004 | CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
| 02/10/2004 | US6689886 Treatment of inflammation and other immune disorders |
| 02/10/2004 | US6689883 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 02/10/2004 | US6689806 Indolinone compounds as kinase inhibitors |
| 02/10/2004 | US6689792 Useful for the treatment of schizophrenia and related psychotic disorders such as parkinson's disease and alzheimer's disease |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689784 Controlling cell apoptosis |
| 02/10/2004 | US6689782 3-piperazinyl-2-diarylurea-quinazolinone derivatives; potentiators of antifungal agents |
| 02/10/2004 | US6689754 Heterocyclic glycyl β-alanine derivatives |
| 02/05/2004 | WO2004011556A1 Site-specific labelling of proteins using cyanine dye reporters |
| 02/05/2004 | WO2004011443A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 02/05/2004 | WO2004011440A1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredint |
| 02/05/2004 | WO2004011439A2 Aryl substituted benzimidazoles and their use as sodium channel blockers |
| 02/05/2004 | WO2004011438A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 02/05/2004 | WO2004010995A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis |
| 02/05/2004 | WO2003074475A3 Substituted aryl ketones |
| 02/05/2004 | WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 02/05/2004 | US20040024399 Method for repairing damaged intervertebral discs |
| 02/05/2004 | US20040024211 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes |
| 02/05/2004 | US20040024206 Pyrimidine compounds |
| 02/05/2004 | US20040024203 Imines such as 4-(3-((3-(2,4-dichlorophenyl)propanoyl)amino)-1-(3-(morpholin-4-yl)propyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-5-yl)benzamide, administered for prophylaxis of Alzheimer's disease |
| 02/05/2004 | US20040024190 Viral polymerase inhibitors |
| 02/05/2004 | US20040024067 Deacetylase inhibitors |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/05/2004 | US20040024040 Inhibitors of GSK-3 and uses thereof |
| 02/05/2004 | US20040024039 Having a steroid C17,20-lyase inhibitory activity; useful as prophylactic or therapeutic agent for prostate and breast cancers |
| 02/05/2004 | US20040024037 Includes a colorant, a solvent and an antibiotic additive produced by binding antibiotic substance to predetermined additive via chemical reaction; improves storage stability and inhibits propagation and growth of bacteria in ink |
| 02/05/2004 | US20040024030 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |
| 02/05/2004 | US20040024023 1-Heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/05/2004 | US20040024010 3-methylidenyl-2-indolinone modulators of protein kinase |